Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Alopecia areata greatly affects quality of life, with many experiencing mental health issues and lacking professional support.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Epidermal stem cells show promise for skin repair and regeneration.

Oral mucosa heals with minimal scarring, offering insights for scarless wound healing.

Engineered skin tissue is a promising tool for safer cosmetic testing.

Bone marrow-derived stem cells improved healing and reduced scarring in second-degree burns in rats.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Minoxidil helps restore thymus size in 22q11.2 deletion syndrome.

Exosomes show promise in treating acute kidney injury by protecting and repairing kidney cells.

The new microwell device helps grow more hair stem cells that can regenerate hair.

New methods to test hair growth treatments have been developed.

Dang Gui may help treat immune-related diseases by boosting and regulating the immune system.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

New treatments are needed for non-scarring alopecia due to current limitations.

Oxyresveratrol promotes hair growth and may help treat hair loss.

Four natural compounds were found to promote hair growth effectively.

Type XVII collagen helps control skin cell growth and may have anti-aging effects.

Type XVII collagen may help prevent skin aging.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

FoxN1 overexpression in young mice harms immune cell and skin development.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

The FDA approved a new Pfizer drug for hair loss in teens.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.